InvestorsHub Logo
Followers 117
Posts 10384
Boards Moderated 1
Alias Born 11/27/2015

Re: tr1205 post# 6635

Sunday, 08/19/2018 9:03:14 PM

Sunday, August 19, 2018 9:03:14 PM

Post# of 9828
Wow, Those are sweet dreams. However, the interesting part is there is so much truth about the potential value down the road. That is exactly why the investor mob should be arriving soon (should of been here already).

The great part about this investment is that there is only about 178 investors in this. I almost feel like most of them aren't even following this. We are getting like 15 trades all day one day, and only 9 the next. On Friday we had 28 trades. When new investors start pouring in this will go way up. When I do DD on this there is such little information, all of which can be found on Oncbiomune's website. Even their facebook page has been quiet for a while.

I really don't see anyone losing money who get in now. Even if the trials fail from this point on, there has been enough proof that this works for some. That alone is enough to make this worth millions. The only down side to this is competition. I always feel when in to these pharmaceutical stocks that there is a race against the competition. After listening and reviewing the AACR documents and videos, there are quite a few companies out there on the scene. Of course I believe Oncbiomune is currently in the lead.

If you want check out this pdf, be warned it is a huge document if you download:

https://www.aacr.org/Documents/canprog18_All.pdf

This was the page I found our poster on:

http://aacr18.posterview.com/nosl/?sessionid=195

OBMP's poster is CT061

The material out there is overwhelming. On the other hand, it just goes to show how important and necessary it is to find cures for cancer. Huge value is successful which I honestly believe we are going to be.

As an investor however, I still have to day trade, sell short term, and hold long term.

GO OBMP$

$OBMP
$OBMP
$OBMP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News